Catalyst Wire Dossier Catalyst Wire Dossier

PEG Intron

pegylated interferon alfa-2b
Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for PEG Intron, covering 2006-05-09 to 2020-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED) [Phase 3]

See pricing